News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Personnel (World)
Actavis (ACT) Announces Proposed Senior Leadership Team Effective Following Completion Of Allergan (AGN) Acquisition 12/16/2014
Gil Beyen Joins Novadip Biosciences Board Of Directors 12/16/2014
Smithers Viscient Delivers Business Improvements As Head Of Chemistry Appointed 12/16/2014
François Garnier Appointed Executive Vice President, General Counsel Of Ipsen (IPN.PA) 12/16/2014
Genentech (RHHBY)'s R&D Chief To Retire; Small Molecule Head Takes Over Top Spot 12/16/2014
Ex-Wyeth (WYE) Head Out Of The Running For Sanofi (SAN.PA) CEO Gig 12/15/2014
Immune Pharmaceuticals, Inc. Elects Daniel Kazado As New Chairman Of The Board 12/15/2014
GUEST COLUMN: Does Size Kill Culture? Prothena Doesn’t Think So 12/12/2014
Mylan Inc. (MYL) To Pay Five Top Execs $32.5 Million Earlier Than Planned As Drugmaker Exits U.S. 12/11/2014
Amarantus BioSciences, Inc. Appoints Elise Brownell, Ph.D., As Senior Vice President Of Operations And Project Management 12/11/2014
Versant Ventures Strengthens Biotechnology Investment Team In North America And Europe 12/10/2014
Bench International Inc. Extends Team In Major Life Science Hubs 12/8/2014
PROMETHERA Biosciences S.A./N.V. Appoints Dr John Tchelingerian As The New Chairman Of The Board 12/8/2014
Innocoll Appoints Tony Zook As CEO As Company Progresses Toward Becoming A Fully-Integrated Commercial Company 12/8/2014
NeuroVive Pharmaceutical AB Employs a Clinical Trial Manager 12/8/2014
Ex-Sanofi (SAN.PA) Employee Claims Ousted CEO Of $34M Kickback Scheme 12/8/2014
Sanofi (SAN.PA) Chairman Says French Tax Burden Is Hindering Hunt For New CEO 12/8/2014
Abingworth Appoints Kurt Von Emster As A Partner In Menlo Park 12/5/2014
Qu Biologics Welcomes Gastroenterologist Dr. Remo Panaccione To IBD Advisory Team 12/4/2014
Pharma-Bio Serv, Inc. (PBSV.OB) Appoints Víctor Sánchez As President And Chief Executive Officer Effective January 1, 2015 12/3/2014
Industry Expert Dr. Stefan Krawielitzki Reinforces The AVA Group 12/1/2014
Hanwha Chemical Sacks 4 Top Biotech Executives 12/1/2014
NuCana Appoints Dr. Paolo Paoletti To Its Board Of Directors 12/1/2014
Novartis AG (NVS) Fires Scientist Who Falsified Data In 6 Research Papers 12/1/2014
Novo Nordisk A/S (NVO) Restructures Executive Board As Chief Of Staff Leaves 11/26/2014
Lundbeck Inc. (LUN.CO) CEO Ulf Wiinberg Resigns After Breach Of Company Rules 11/25/2014
Takeda Pharmaceuticals President Doug Cole Quits 11/24/2014
Bone Therapeutics Appoints Dr. Guy Heynen As Chief Clinical And Regulatory Officer 11/24/2014
Verona Pharma (VRP.L) Release: Appointment Of Dr. David Ebsworth As Non-Executive Chairman Of The Board Of Directors 11/24/2014
Sanofi (SAN.PA) Creates Candidate Shortlist For Top CEO Job: Report 11/21/2014
Klox Technologies Announces Executive Appointments, Names New CCO, CFO 11/21/2014
Jim Hamilton Appointed President & CEO Of Neptune Technologies & Bioressources Inc. 11/21/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Appoints New General Manager Of U.S. Business 11/20/2014
Nosopharm Hires Four New International Experts To Its Scientific Advisory Board 11/18/2014
Vectura Group plc (VEC.L) Appoints Andrew Oakley As Group CFO 11/18/2014
Allergy Therapeutics plc Appointment Of A Non-Executive Director 11/18/2014
Ablynx (ABLYF) Appoints Johan Heylen As Chief Commercial Officer 11/18/2014
Intercept Pharmaceuticals (ICPT) Appoints Lisa Bright As Head Of Europe 11/17/2014
With No Leader, Sanofi (SAN.PA) Faces Battle To Sell Pipeline Ambitions 11/14/2014
Caligor Broadens Leadership Team to Support International Growth 11/14/2014
Moberg Pharma AB (Formerly known as Moberg Derma): Moberg Pharma’s Nomination Committee Appointed 11/11/2014
Alchemia (ACL.AX) CEO Steps Down 11/11/2014
New Management Organisation Of The Haselmeier Group 11/10/2014
Horizon Pharma plc.  (HZNP) Appoints John J. Kody As Executive Vice President And Chief Commercial Officer 11/6/2014
Firing Of Sanofi (SAN.PA) CEO Mirrors Teva Pharmaceutical Industries Limited (TEVA)'s 2013 Shakeup 11/6/2014
Cancer Vaccine Specialist Targovax Appoints Gunnar Gårdemyr As New CEO 11/5/2014
Reckitt Benckiser Plc (RB.L) Unveils Name And CFO For Pharma Unit Being Split Off 11/4/2014
Beximco Pharmaceuticals Release: Board Appointment 11/3/2014
Off With Their Heads! BioSpace's Favorite CEOs Who Got The Axe In 2014 11/3/2014
aTyr Pharma Inc. Appoints Fred Ramsdell, Ph.D., As Vice President, Immunology 11/3/2014
Trino Therapeutics Strengthens Its Management Team And Board Of Directors As Clinical Development Of Its Lead Candidate Is Extended 11/3/2014
Change In Siegfried’s Executive Committee 11/3/2014
Sanofi (SAN.PA) Ousts CEO After Clash Over Strategy 10/31/2014
Sanofi (SAN.PA) CEO Wrote To Board Asking To Keep His Job 10/31/2014
AusBiotech Ltd. Announces New Chairman And Directors 10/30/2014
ABIVAX Strengthens Executive Management Team With Senior Appointments 10/30/2014
Sanofi (SAN.PA) Approached AstraZeneca PLC (AZN)'s Soriot For CEO Role 10/30/2014
Sanofi (SAN.PA) Mulls Firing CEO Viehbacher 10/29/2014
BioNet Appoints New COO And Accelerates The Development Of New Recombinant Pertussis Vaccine 10/28/2014
Sirona Biochem Names Attila Hajdu As Chief Business Development Officer 10/27/2014
Cardio3 BioSciences Appoints Dr. Warren Sherman As Chief Medical Officer 10/23/2014
New Role Created At GlaxoSmithKline (GSK)'s Vaccines Unit 10/23/2014
aTyr Pharma Inc. Appoints John C. McKew, Ph.D., As Vice President, Research 10/22/2014
ProNAi Therapeutics, Inc. Strengthens Senior Management Team To Advance DNAi®-based Oncology Therapeutics 10/22/2014
Therapix Names Jan Turek CEO 10/20/2014
Shire's Finance Chief Jumps Ship 10/20/2014
Bruno Lucidi Appointed Permanent CEO Of Karolinska Development AB 10/15/2014
MEDA: Nomination Committee Appointed 10/15/2014
Bart Filius Joins Galapagos NV (GLPG.BR) As CFO 10/15/2014
Core Team At Ranbaxy Laboratories (RANBAXY.BO) U.S. Unit Resigned: Report 10/15/2014
Vetter Announces Personnel Changes In Its Development Service Division 10/15/2014
Mazor Robotics Promotes Christopher Prentice To CEO Of Its U.S. Subsidiary 10/14/2014
Pharmalink AB Elects Bengt Julander As Chairman 10/14/2014
PuriCore's CEO To Retire 10/14/2014
Stora Enso Has Appointed Johanna Hagelberg As Executive Vice President Sourcing As Of 1 November 2014. This Is A New Role In Stora Enso's Group Leadership Team 10/14/2014
Sanofi (SAN.PA) Looks To Rival AstraZeneca PLC (AZN) For New UK & Ireland Head 10/13/2014
Aymeric Le Chatelier Joins Ipsen (IPN.PA) As Executive Vice President, Chief Financial Officer 10/10/2014
Three Executives To Leave Novartis AG (NVS) After GlaxoSmithKline (GSK), Eli Lilly and Company (LLY) Deals 10/9/2014
Neovacs SA Installs A New International Scientific Committee In New York 10/9/2014
Mezzion Pharma Appoints Jefferson Gregory To Board Of Directors 10/9/2014
Cortendo Appoints Robert Lutz As Chief Business Officer 10/9/2014
TRANSGENE (ENX:TNG) Announces Management Changes 10/9/2014
Roche (RHHBY)'s Severin Schwan Still The Best Paid Swiss CEO 10/8/2014
AEterna Zentaris (AEZS) Appoints Phil Theodore As Chief Administrative Officer, General Counsel And Corporate Secretary 10/7/2014
Public Health Agency of Canada Release: Government Of Canada Announces A Second Mobile Lab And Team To Be Deployed To West Africa To Assist In The Ebola Outbreak 10/6/2014
Sanofi (SAN.PA) French Head To Leave At End Of 2014 10/3/2014
CEO Torbjörn Bjerke Leaves Karolinska Development AB And Board Member Klaus Wilgenbus Is Appointed Acting CEO 9/30/2014
Jerome H. Kim Appointed As Director General Of IVI 9/30/2014
WuXi PharmaTech Co., Ltd. Announces Appointment Of William R. Keller To Board 9/30/2014
ADC Therapeutics Expands Team 9/30/2014
LINK Appoints New CEO 9/29/2014
Protalix Biotherapeutics, Inc. (PLX) Appoints Moshe Manor As President And CEO 9/29/2014
Horizon Pharma plc.  (HZNP) Commercial Chief Resigns; Executive Committee Formed 9/29/2014
RBS Chairman To Head Embattled GlaxoSmithKline (GSK) 9/25/2014
Highland Therapeutics Appoints Dr. Floyd R. Sallee Chief Medical Officer 9/24/2014
TRANSGENE (ENX:TNG) Appoints Eric Quéméneur, PhD As Executive Vice President In Charge Of Research & Development 9/23/2014
Avillion Appoints Jarrod Longcor As Chief Business Officer 9/23/2014
BioLife Solutions, Inc. (BLFS.OB) Announces The Addition Of Jason Acker, MBA, PhD And Anthony Davies, PhD To Its Scientific Advisory Board 9/23/2014
CEVEC Appoints New Management Team 9/22/2014
Celgene (CELG) Appoints Tuomo Pätsi As President Of EMEA And Commits To Continue Delivering Innovative Solutions To Meet Patient Needs Across The Region 9/19/2014
Mary Tanner Appointed To Genticel’s Supervisory Board As Independently-Acting Member 9/19/2014
AmpliPhi Biosciences Corporation (APHB) Announces Departure Of CEO 9/19/2014
Horizon Pharma plc.  (HZNP) Announces Board Of Directors Following Closing Of Acquisition Of Vidara Therapeutics International plc 9/19/2014
Merck KGaA (MKGAF.PK) Appoints New Deputy Chief As CEO Kley’s Succession Is Pondered 9/18/2014
Nexvet Expands Australian Veterinary Biologics Research Centre 9/15/2014
Scientific Founder Of Intercept Pharmaceuticals (ICPT) Joins Tiziana Life Sciences Plc 9/12/2014
Medgenics, Inc. Announces The Appointment Of Scott Applebaum As Chief Legal Officer 9/10/2014
To-BBB technologies BV Taps A New CEO 9/9/2014
Bruno Lucidi New CEO In Karolinska Development AB Oncology Companies 9/8/2014
CollPlant Names Dr. Nadav Orr Vice President Research And Development 9/8/2014
Aptose Biosciences Recruits Stephen B. Howell, M.D. To Act In The Capacity Of Chief Medical Officer 9/8/2014
Pivotal Therapeutics Inc. Appoints Accomplished Healthcare And Investment Industry Veteran, Prakash Gowd, As Chief Financial Officer 9/8/2014
Ex-Genentech (RHHBY) Boss Resigns From Roche (RHHBY)'s Board; Fears Conflict Of Interest With New CEO Post At Google Inc.'s Calico 9/4/2014
Nabriva Therapeutics Appoints Dr. Colin Broom As CEO 9/3/2014
ICON Appoints Dr. Ira Spector As Executive Vice President, Analytics And Consulting 9/3/2014
Cerenis Therapeutics, Inc. Appoints Dr. Richard C. Pasternak As Chairman 9/3/2014
TiGenix Appoints Chief Medical Officer And Vice President Medical Affairs And New Product Commercialisation 9/2/2014
Sierk Pötting To Be The New CFO (Chief Financial Officer) Of BioNTech Group 9/2/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent 9/2/2014
Amarantus BioSciences, Inc. Appoints Iain Ross To Board Of Directors 8/29/2014
Isogenica Limited Brings In A New CEO 8/28/2014
Moberg Pharma AB (Formerly known as Moberg Derma)’s Head Of U.S. Operations To Resign By End Of January 2015 8/28/2014
Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex Inc. 8/27/2014
Nordic Nanovector: The Board Appoints Mr. Luigi Costa As New CEO 8/26/2014
Miriam Monge To Join Sartorius Stedim Biotech As Director Of Marketing For Integrated Solutions 8/26/2014
Pharmaceutical Executive Joins Mesoblast Limited (MSB.AX) As Chief Financial Officer 8/25/2014
Compugen Ltd. (CGEN) Appoints Mr. Ari Krashin As Chief Financial Officer 8/25/2014
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team 8/21/2014
ELC Group Appoints Dr. Siddharth Chachad As Head Of Global Clinical Development And Medical Affairs 8/20/2014
Masters Speciality Pharma Appoints Partner Development Director 8/19/2014
Dr. Paul Blake To Take Executive Role As Chief Development Officer 8/15/2014
Forward Pharma Announces Appointment Of Dr. Jan G. J. Van De Winkel To Board Of Directors 8/13/2014
GE Healthcare Life SciencesOlivier Loeillot Appointed GM Asia Commercial Bioprocess 8/13/2014
Ex-Merck & Co., Inc. (MRK) Exec Appointed New President And CEO Of Medivir AB (MVRBF) 8/12/2014
Joel Sendek, Leading Wall Street Biotech Analyst, Joins Forward Pharma As Chief Financial Officer 8/11/2014
GlaxoSmithKline (GSK) Close To Poaching Royal Bank of Scotland (RBS)'s Sir Philip Hampton As Next Chairman 8/8/2014
WuXi PharmaTech Co., Ltd. Announces Appointment Of Walter Kwauk To Board 8/8/2014
Cortendo Appoints Matthew Pauls As CEO 8/7/2014
As Sanofi (France) (SAN.PA) Pushes to Grow Faster, A Top U.S. Exec Is Leaving 8/1/2014
Rafarma Pharmaceuticals Announces New President As Part Of Pending Acquisition Of Majority Interest 7/30/2014
ImaginAb, Inc. Appoints Roger Crystal, MD As Vice President of Business Development 7/28/2014
Amarantus BioSciences, Inc. Appoints Donald D. Huffman To Board Of Directors 7/28/2014
Management Reshuffle At Ranbaxy Laboratories (RANBAXY.BO): Arno Gessner Promoted, New R&D Head Named 7/28/2014
Bristol-Myers Squibb Company (BMY) Appoints Jitendra Tyagi As India Country Head 7/24/2014
Milestone Pharmaceuticals Appoints Chief Medical Officer 7/21/2014
Peptidream Announces The Appointment Of Dr. Keiichi Masuya As Chief Operating Officer (COO) At Peptidream Inc. 7/17/2014
Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board 7/17/2014
Teva Pharmaceutical Industries Limited (TEVA) Denies Shareholder Claim That A Chairman Has Been Selected 7/15/2014
Merck KGaA (MKGAF.PK) Hires A New Global Head Of R&D 7/15/2014
Immune Pharmaceuticals, Inc. Appoints Cameron Durrant, MD, MBA To Board Of Directors 7/14/2014
ScinoPharm President & CEO To Retire, Successor Named 7/11/2014
Prima Biomed (PRR.AX) Appoints New Chief Executive Officer 7/9/2014
Director Ying Han Resigns from WuXi PharmaTech Co., Ltd. Board 7/9/2014
Michael Balmuth Joins SV Life Sciences As Partner 7/8/2014
Oxford BioTherapeutics Appoints Dr. Eugen Leo As Head Of Clinical Development 7/8/2014
Oxford Immunotec Limited (OXFD) Appoints Louis O'Dea Chief Medical Officer 7/7/2014
Pharmalink AB Strengthens its Board Of Directors 7/7/2014
VolitionRX Announces New Chief Financial Officer 7/1/2014
ALK-Abello A/S Appoints New Executive Vice President For Product Supply 7/1/2014
ProSensa Holding N.V. (RNA) Strengthens Its Management Team And Supervisory Board With Key Appointments 6/30/2014
Ipsen (IPN.PA) Joins PHARNEXT's Board Of Directors 6/30/2014
Serial Entrepreneur Dr. Peter Hirth Joins Nuevolution As Corporate Advisor 6/26/2014
Helsinn Therapeutics (US) Inc. Strengthens Its Board Of Directors 6/25/2014
ThromboGenics NV (TBGNF) Rules Out Sale, CFO Calls It Quits 6/24/2014
With Boardroom Drama Behind Him, Teva Pharmaceutical Industries Limited (TEVA) Chairman Phillip Frost To Step Down By End Of The Year 6/19/2014
PSI Names Jim Kostka, Director of Project Management, North America 6/18/2014
Valeant Pharmaceuticals International (VRX) Announces Planned Management Departure 6/16/2014
Protalix Biotherapeutics, Inc. (PLX) CEO Will Retire This Year 6/13/2014
Pivotal Therapeutics Inc. Engages Kilmer Lucas For Cross-Border Investor Relations 6/12/2014
Foamix Establishes U.S. Subsidiary And Strengthens Executive Management With Appointment Of Senior U.S. Leadership Team 6/12/2014
Aerocrine Announces Leadership Changes 6/12/2014
AstraZeneca PLC (AZN) Investors Still Want To Link Executive Pay To Pipeline Delivery 6/11/2014
DNA Electronics Ltd. Appoints Nick McCooke As Chief Business Officer 6/10/2014
Israel Stem Cell Developer BrainStorm Cell Therapeutics Inc. Appoints Tony Fiorino, MD, PhD As CEO 6/9/2014
Chiltern International Ltd. And Society For Applied Pharmacological Sciences (SSFA) Announce The Appointment Of Dr. Marco Romano As President Of SSFA 6/9/2014
Immune Pharmaceuticals, Inc. Appoints Gad Berdugo To Board Of Directors And Karin Hehenberger, M.D., Ph.D To Senior Vice President 6/6/2014
Dieter Weinand Tapped To Be President Of Bayer HealthCare Pharmaceuticals (BAYA.F) 6/6/2014
Bayer AG (BAYZF)'s CEO To Quit In 2016, CFO Moves Over To Lead Strategy 6/5/2014
Teva Pharmaceutical Industries Limited (TEVA) Reorganizes, Makes Senior Leadership Changes 6/4/2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus As Chief Medical Officer 6/3/2014
Anergis Appoints Dr. Vanya Beltrami As Director Product Development 6/3/2014
Kymab Strengthens Management Team With Two Senior Appointments 6/3/2014
Novartis AG (NVS) Appoints Merck & Co., Inc. (MRK) Executive As Cancer Chief 6/3/2014
MGB Biopharma Limited Expands Scientific Advisory Board (SAB) With Medical Microbiologist Dr Stephanie Dancer 6/2/2014
Ascendis Pharma A/S Appoints Martin Auster, M.D., As Chief Business Officer 6/2/2014
SV Life Sciences Appoints Three New Venture Partners 6/2/2014
Gensignia Appoints CEO 5/30/2014
Bavarian Nordic (BAVA.CO) Taps Paul Chaplin, Ph.D. For President & CEO Post 5/29/2014
Chiltern International Ltd. Appoints Dr. Michael Wisniewski As Senior Executive Director, Biometrics 5/28/2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) With Experts In Chronic Pain 5/27/2014
Swedish Orphan BiovitrumAppoints Kirsti Gjellan As Senior Vice President Manufacturing Operations 5/27/2014
Domain Therapeutics Appoints Dr Youssef L. Bennani As Chairman Of The Board 5/27/2014
Appointment Of Jens Klein As Managing Director Of AMSilk GmbH 5/23/2014
AmpliPhi Biosciences Corporation (APHB) Announces Appointment of New Board Member 5/23/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Nomination Of Two New Directors 5/22/2014
Dr. Brian Zambrowicz, Ph.D Has Joined Nuevolution As Director And Senior Scientific Advisor To The Board Of Directors 5/21/2014
Peter George Joins Board Of ErgoMed As Non-Executive Director 5/21/2014
Jazz Pharmaceuticals plc (JAZZ) Names Russell J. Cox To Position Of Chief Operating Officer 5/20/2014
Symphogen A/S Finds A New Home, Appoints Chief Manufacturing Officer 5/19/2014
Avastin And Lucentis Pioneer Joins Tiziana Life Sciences 5/19/2014



//-->